Sepone - ringshyppighedenpå grund af bivirkninger i disse undersøgelser var 5, 0% for patienter, der fik Dynastat og 4, 3% for patienter, der fik placebo.
20 discontinuation rate due to adverse events in these studies was 5.0% for patients receiving Dynastat and 4.3% for patients receiving placebo.